Drug Discovery Services

The Drug Discovery Services at ResolveMass Laboratories Inc. focuses on the scientific and technical aspects of early-stage drug discovery, from hit identification to lead optimization and preclinical readiness. This section is designed for biotech start-ups, virtual pharma companies, and academic spin-offs seeking practical insights into outsourced discovery workflows.

Our articles explore medicinal chemistry strategies, complex small-molecule and peptide synthesis, structure–activity relationship (SAR) development, impurity profiling, and advanced analytical characterization that support informed decision-making in discovery programs. We also cover challenges associated with scalability, molecular complexity, and data quality required for downstream IND-enabling activities.

Rather than high-level overviews, this category emphasizes chemistry-driven problem solving, experimental considerations, and regulatory-aware data generation relevant to real drug discovery projects. The content reflects ResolveMass’s role as a chemistry-focused Drug Discovery CRO, supporting programs where in-house infrastructure is limited but scientific rigor is essential.

This category serves as a knowledge resource for teams aiming to translate early molecular concepts into well-characterized, development-ready candidates.